Omega Diagnostics Group Plc
| London Stock Exchange: ODX
Omega Diagnostics Group Plc engages in distribution and selling of the medical products, which focuses on the immunoassay, in-vitro diagnostics market. The company operates through three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease. The Allergy and Autoimmune segment specializes in the research, development, production and marketing of in-vitro Allergy and Autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases. The Food Intolerance segment specializes in the research, development and production of kits to aid the detection of immune reactions to food. The Infectious Diseases segment specializes in the research, development and production and marketing of kits to aid the diagnosis of infectious diseases. Omega Diagnostics Group was founded by Andrew Shepherd on September 19, 2006 and is headquartered in Alva, the United Kingdom.